南新制药(688189.SH)：聘任陈健旭为总经理

Core Viewpoint - Nanxin Pharmaceutical (688189.SH) announced the resignation of its General Manager, Zhang Shixi, due to work adjustments, effective immediately upon delivery of the resignation report to the board [1] Group 1: Management Changes - Zhang Shixi will continue to serve as a director, chairman, and the convener of the board's strategic committee after resigning as General Manager [1] - The company held its 22nd meeting of the second board of directors on February 11, 2026, where it approved the appointment of Chen Jianxu as the new General Manager [1] - Chen Jianxu's term as General Manager will last until the end of the current board's term [1]